News 2015
Study Finds Marketplace Silver Plans Offer Poor Access To HIV Drugs
Bottles of antiretroviral drug Truvada
In most states, consumers with HIV or AIDS who buy silver-level plans on the insurance marketplaces find limited coverage of common drug regimens they may need and high out-of-pocket costs, according to a new analysis.
Read more: Study Finds Marketplace Silver Plans Offer Poor Access To HIV Drugs
Shop Around for Health Plans to Get the Best Coverage
Shop around
The third Open Enrollment period for Marketplace health coverage began on November 1, 2015 and runs through January 31, 2016. Did you or someone you know have health coverage through Healthcare.gov or your state's Marketplace for coverage in 2015? If so, now is the time to compare plan options for next year! Choosing the right health plan is especially important for people living with HIV.
Read more: Shop Around for Health Plans to Get the Best Coverage
FDA Approves New Treatment for HIV
Genvoya, a single-tablet combination antiretroviral regimen
The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.
In Baltimore, Distrust of Doctors Impedes HIV Prevention
Javius Cain, a co-chair of BTAN Baltimore and a social worker at the Institute of Human Virology at the University of Maryland School of Medicine, Josephine Ayankoya, the mobilization coordinator for Black AIDS Institute and Jamal Hailey, co-chair of BTAN Baltimore and the director of programs for Special Teens At-Risk, Together Reaching Access, Care and Knowledge (STAR TRACK) at the PrEP training session for health care workers at the Department of Health and Mental Hygiene in Baltimore, Md. (Freddie Allen/BAI)
The complicated history between Baltimore's Black community and medical establishment has left many residents wary of health-care providers, making it much harder to reach at-risk populations with lifesaving HIV prevention and treatment messages.
Read more: In Baltimore, Distrust of Doctors Impedes HIV Prevention
In This Issue
It's no secret that we have the tools to break the back of the AIDS epidemic in America. We've been talking about this for years now and with treatment as prevention and pre-exposure prophylaxis (PrEP) we now actually can prove that we have the mechanisms to stop both HIV's transmission and acquisition.